Longevity medicine programme
Longevity medicine programme has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 10, 2026: “Evidence for longevity medicine: a retrospective cohort study of multi-domain health improvement in a structured preventive health programme”.
1 paper studies it5 findingsUpdated
See all 1 papers on longevity medicine programme
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Lipid markers improved, including reductions in LDL cholesterol, ApoB, and triglycerides (all p < 0.001).”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of longevity medicine programme find?
5Studies of longevity medicine programme measured 5 outcomes, among them visceral adipose tissue, HbA1c and C-reactive protein.
Visceral adipose tissue
downin humans1
1 study
Visceral adipose tissue
downin humans1
Longevity medicine programme is linked with lower visceral adipose tissue in humans (paired comparison of baseline and follow-up assessments, uncontrolled).
Humanspaired comparison of baseline and follow-up assessments, uncontrolledvisceral adipose tissuen = 1,122
HbA1c
downin humans1
1 study
HbA1c
downin humans1
Longevity medicine programme is linked with lower HbA1c in humans (paired comparison of baseline and follow-up assessments, uncontrolled).
Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394
C-reactive protein
downin humans1
1 study
C-reactive protein
downin humans1
Longevity medicine programme is linked with lower C-reactive protein in humans (paired comparison of baseline and follow-up assessments, uncontrolled).
Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394
LDL cholesterol
downin humans1
1 study
LDL cholesterol
downin humans1
Longevity medicine programme is linked with lower LDL cholesterol in humans (paired comparison of baseline and follow-up assessments, uncontrolled).
Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394
VO2MAX
upin humans1
1 study
VO2MAX
upin humans1
Longevity medicine programme is linked with better VO2MAX in humans (paired comparison of baseline and follow-up assessments, uncontrolled).
Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 841